Offer enfortumab vedotin in combination with pembrolizumab as first line treatment to patients with advanced/metastatic UTUC.
#UTUC#EAUguidelines
https://t.co/9QUXM49VPH
CHMP gives a positive recommendation for Enfortumab Vedotin and Pembrolizumab in 1st line advanced UC. Paving the way for use in Europe. https://t.co/FcipHD6VPs
Unser Bundestrainer, Herr Julian Nagelsmann, mit einer ganz persönlichen Botschaft an die beiden Parteien BSW und AfD.
Und an alle anderen Populisten da draußen....
#WeAreOne#DeutschlandEinigVaterland
Trump posted today, “IF THIS CAN HAPPEN TO ME, IT CAN HAPPEN TO ANYONE!” I’ll remember that the next time I cheat on my third wife with a porn star and have to pay her off because I’m running for President.
Magnifique journée pour l'inauguration de notre nouvel Institut de Cancerologie et d'Imagerie, l'ICI, tourné vers l'innovation et l'excellence pour tous les bretons du territoire !
Join us for an interactive live seminar on ‘Targeted therapies in GU Cancers’ from #EAU2024. Explore biomarker breakthroughs, BRCA mutations in mCRPC, and case studies in precision medicine. Register free here👉 https://t.co/Hrkol3YTn4 #EAU2024@FSchlurmann @evacomperat @Roubaud
The final results of #POUT adjuvant trial in Upper Tract Urothelial cancer (UTUC) adjuvant trial are now published in @JCO_ASCO. This is a landmark study in the field and @AlisonBirtle + team should be celebrated.
5-year DFS (1EP): 62% vs. 45%, HR 0.55 (95% CI, 0.38-0.80, p=.001)
5-year OS: 66% vs. 57%, uHR = 0.68 (95% CI, 0.46 to 1.00, P = .049)
No differences in QoL
@mishamichien@Fabcapd Il fait lui même comme dans la grande majorité des pays de cette belle planète. Les patients français sont gâter mais ne se rendent même pas compte..